Î÷¹ÏÊÓƵ

[Skip to Navigation]
Sign In

September 2024 - January 2020

Decade

Year

Issue

December 2022, Vol 3, No. 12

JAMA Forum

The New US National Biodefense Strategy—Necessary but Not Sufficient

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e225206. doi:10.1001/jamahealthforum.2022.5206

This JAMA Forum discusses the Biden administration’s recently released National Biodefense Strategy and recommends that the implementation of this national strategy be accompanied by recommendations from the Commonwealth Fund Commission.

Health Workforce Issues More Conspicuous After Onset of COVID-19

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e225256. doi:10.1001/jamahealthforum.2022.5256

This JAMA Forum discusses the problems facing the health care workforce in the wake of the COVID-19 pandemic, including a shortage of workers and the challenge of increasing wages, and highlights issues that policy makers and leaders may consider to address these problems.

Principles to Guide the US Toward Better Health for All

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e225359. doi:10.1001/jamahealthforum.2022.5359

This JAMA Forum discusses ways to work toward health equity in the US, suggests structural changes that could be implemented to remedy historical underinvestments in health, and provides ideas for how to gain public trust and buy-in for policies to achieve these goals.

Medicaid as a Potential New Third Rail of US Politics

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e225492. doi:10.1001/jamahealthforum.2022.5492

This JAMA Forum discusses upcoming debt ceiling debates in the US Congress and potential cuts to entitlement programs within the context of the current wider reach of Medicaid than Medicare, Medicaid expansion under the Affordable Care Act, and the possible end to the COVID-19 public health emergency and a recession.

Viewpoint

An 8-Factor Regulatory Framework to Facilitate Patient Compassionate Use Access

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e224627. doi:10.1001/jamahealthforum.2022.4627

This Viewpoint assesses patient access to compassionate use treatments for medical care and advocates a framework for helping to facilitate such access.

Negotiating Drug Prices in the US—Lessons From Europe

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e224801. doi:10.1001/jamahealthforum.2022.4801

This Viewpoint describes European drug price negotiation practices and compares them with practices in the US.

Cost-Sharing Reform for Chronic Disease Treatments as a Strategy to Improve Health Care Equity and Value in the US

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e224804. doi:10.1001/jamahealthforum.2022.4804

This Viewpoint discusses cost-sharing reform for chronic disease treatments as a strategy to improve patient outcomes, promote health equity, and minimize long-term health care expenditures in the US.

Original Investigation

Trends in and Factors Contributing to the Slowdown in Medicare Spending Growth, 2007-2018

Abstract Full Text
open access has audio
JAMA Health Forum. 2022;3(12):e224475. doi:10.1001/jamahealthforum.2022.4475

This cross-sectional study evaluates factors contributing to the slowdown in Medicare per-beneficiary spending growth.

Assessment of Churn in Coverage Among California’s Health Insurance Marketplace Enrollees

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e224484. doi:10.1001/jamahealthforum.2022.4484

This cross-sectional study used administrative data from California’s Affordable Care Act marketplace, Covered California, and survey data from a representative sample of enrollees to identify factors associated with enrollment turnover, or churn, in the individual insurance marketplaces.

Human Papillomavirus Vaccine Administration Trends Among Commercially Insured US Adults Aged 27-45 Years Before and After Advisory Committee on Immunization Practices Recommendation Change, 2007-2020

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e224716. doi:10.1001/jamahealthforum.2022.4716

This cohort study examines the association between the Advisory Committee on Immunization Practices recommendation update for patient-clinician shared decision-making and human papillomavirus vaccine administration among US adults aged 27 to 45 years.

Duration and Continuity of Medicaid Enrollment Before the COVID-19 Pandemic

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e224732. doi:10.1001/jamahealthforum.2022.4732

This cross-sectional study uses Medicaid data to assess factors associated with the duration and continuity of Medicaid enrollment.

Association of Medicare Beneficiary and Hospital Accountable Care Organization Alignment With Surgical Cost Savings

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e224817. doi:10.1001/jamahealthforum.2022.4817

This cohort study analyzes US Medicare data to examine surgical episode costs before and after accountable care organization implementation among assigned and unassigned beneficiaries treated at participating and nonparticipating hospitals.

Trends in Ransomware Attacks on US Hospitals, Clinics, and Other Health Care Delivery Organizations, 2016-2021

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e224873. doi:10.1001/jamahealthforum.2022.4873

This cohort study examines the frequency and characteristics of ransomware attacks on health care delivery organizations.

Performance of Physician Groups and Hospitals Participating in Bundled Payments Among Medicare Beneficiaries

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e224889. doi:10.1001/jamahealthforum.2022.4889

This cohort study evaluates the association between bundled payments and episode outcomes per medical and surgical episodes for physician groups compared with hospitals participating in the Medicare bundled payments initiative.

Research Letter

Equity Implications of Hospital Penalties During 4 Years of the Comprehensive Care for Joint Replacement Model, 2016 to 2019

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e224455. doi:10.1001/jamahealthforum.2022.4455

This cross-sectional study assesses the penalties against hospitals under the Comprehensive Care for Joint Replacement model mandated by Medicare, with particular attention to safety-net hospitals and those serving a high proportion of Black or Hispanic patients.

Characteristics of Hospitals Eligible for Rural Emergency Hospital Designation

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e224613. doi:10.1001/jamahealthforum.2022.4613

This cross-sectional study compares the characteristics, finances, services, and challenges at hospitals that are eligible vs not eligible to become rural emergency hospitals.

Value-Based Pricing of US Prescription Drugs: Estimated Savings Using Reports From the Institute for Clinical and Economic Review

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e224631. doi:10.1001/jamahealthforum.2022.4631

This cross-sectional study estimates how annual US drug spending would change if prices for prescription drugs were set at the value-based price.

Beneficiary Switching Between Traditional Medicare and Medicare Advantage Between 2016 and 2020

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e224896. doi:10.1001/jamahealthforum.2022.4896

This cohort study examines switching behavior in enrollment in Medicare Advantage and traditional Medicare.

In the News

Report on Long COVID Urges Actions to Address Needs of Patients, Caregivers

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e225254. doi:10.1001/jamahealthforum.2022.5254

US COVID-19 Vaccine Costs Expected to Soar if Funding for Federal Program Ends

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e225376. doi:10.1001/jamahealthforum.2022.5376

Most Nursing Home Staff, Residents Not Up to Date with COVID-19 Vaccinations

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e225467. doi:10.1001/jamahealthforum.2022.5467
Special Communication

The Settlement of the Blue Cross Blue Shield Antitrust Litigation: Creating a New Potential Catalyst for Health Insurance Industry Restructuring

Abstract Full Text
open access has active quiz
JAMA Health Forum. 2022;3(12):e224737. doi:10.1001/jamahealthforum.2022.4737

This Special Communication evaluates the settlement of the antitrust lawsuit against the Blue Cross Blue Shield Association to understand how the new requirements will affect the health insurance markets and health policy in the US.

Editorial

The Comprehensive Care for Joint Replacement Model—Potential Implications for Equity

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e224459. doi:10.1001/jamahealthforum.2022.4459

Public Access to Scientific Research Findings and Principles of Biomedical Research—A New Policy for the Î÷¹ÏÊÓƵ

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e225227. doi:10.1001/jamahealthforum.2022.5227
Correction

Errors in Figure 1

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e224770. doi:10.1001/jamahealthforum.2022.4770

Error in Abstract, Results, and Discussion

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e224857. doi:10.1001/jamahealthforum.2022.4857
JAMA Health Forum Masthead

JAMA Health Forum

Abstract Full Text
open access
JAMA Health Forum. 2022;3(12):e220720. doi:10.1001/jamahealthforum.2022.0720
×